Key result
Cholesterol embolization is linked to early renal allograft failure and severe vascular rejection requiring nephrectomy.
Case Report (n=1)
Highlights cholesterol embolization as a potential cause of early graft failure and severe vascular rejection in renal allograft recipients.
Answers are grounded in this paper and cite their sources.
CE may cause dysfunction even in young allograft recipients; case report leaves open true incidence and management implications.
Cholesterol embolization (CE) is a well-known cause of renal dysfunction, often leading to irreversible renal failure most often in elderly patients. However, because of its unspecific and subclinical appearance, CE is often misdiagnosed. As donors and recipients of increasing age or with prominent atherosclerotic disease are accepted for transplantation, CE in renal allografts may become more prevalent. Here, we report a case of a 31-year-old second renal allograft recipient with CE as a cause of early graft failure, followed by severe vascular rejection, eventually requiring nephrectomy.
No takes yet. Share an insight, caveat, or question.
Renders et al. (2009) conducted a case report in Cholesterol embolization in a renal allograft recipient (n=1). Cholesterol embolization was evaluated on Early graft failure, severe vascular rejection, and nephrectomy. Cholesterol embolization in a 31-year-old second renal allograft recipient led to early graft failure and severe vascular rejection requiring nephrectomy.
Synapse has enriched 10 related papers. Consider them for comparative context: